358 related articles for article (PubMed ID: 18599482)
1. The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains.
Winborn BJ; Travis SM; Todi SV; Scaglione KM; Xu P; Williams AJ; Cohen RE; Peng J; Paulson HL
J Biol Chem; 2008 Sep; 283(39):26436-43. PubMed ID: 18599482
[TBL] [Abstract][Full Text] [Related]
2. Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3.
Nicastro G; Todi SV; Karaca E; Bonvin AM; Paulson HL; Pastore A
PLoS One; 2010 Aug; 5(8):e12430. PubMed ID: 20865150
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.
Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on ataxin-3 deubiquitinating activity.
Weeks SD; Grasty KC; Hernandez-Cuebas L; Loll PJ
J Biol Chem; 2011 Feb; 286(6):4555-65. PubMed ID: 21118805
[TBL] [Abstract][Full Text] [Related]
5. Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways.
Chai Y; Berke SS; Cohen RE; Paulson HL
J Biol Chem; 2004 Jan; 279(5):3605-11. PubMed ID: 14602712
[TBL] [Abstract][Full Text] [Related]
6. Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates.
Zhong X; Pittman RN
Hum Mol Genet; 2006 Aug; 15(16):2409-20. PubMed ID: 16822850
[TBL] [Abstract][Full Text] [Related]
7. Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP.
Scaglione KM; Zavodszky E; Todi SV; Patury S; Xu P; Rodríguez-Lebrón E; Fischer S; Konen J; Djarmati A; Peng J; Gestwicki JE; Paulson HL
Mol Cell; 2011 Aug; 43(4):599-612. PubMed ID: 21855799
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3.
Todi SV; Winborn BJ; Scaglione KM; Blount JR; Travis SM; Paulson HL
EMBO J; 2009 Feb; 28(4):372-82. PubMed ID: 19153604
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3.
Chow MK; Mackay JP; Whisstock JC; Scanlon MJ; Bottomley SP
Biochem Biophys Res Commun; 2004 Sep; 322(2):387-94. PubMed ID: 15325242
[TBL] [Abstract][Full Text] [Related]
10. Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites.
Nicastro G; Masino L; Esposito V; Menon RP; De Simone A; Fraternali F; Pastore A
Biopolymers; 2009 Dec; 91(12):1203-14. PubMed ID: 19382171
[TBL] [Abstract][Full Text] [Related]
11. The effects of the polyglutamine repeat protein ataxin-1 on the UbL-UBA protein A1Up.
Riley BE; Xu Y; Zoghbi HY; Orr HT
J Biol Chem; 2004 Oct; 279(40):42290-301. PubMed ID: 15280365
[TBL] [Abstract][Full Text] [Related]
12. Mode of substrate recognition by the Josephin domain of ataxin-3, which has an endo-type deubiquitinase activity.
Satoh T; Sumiyoshi A; Yagi-Utsumi M; Sakata E; Sasakawa H; Kurimoto E; Yamaguchi Y; Li W; Joazeiro CA; Hirokawa T; Kato K
FEBS Lett; 2014 Nov; 588(23):4422-30. PubMed ID: 25448680
[TBL] [Abstract][Full Text] [Related]
13. Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3.
Berke SJ; Chai Y; Marrs GL; Wen H; Paulson HL
J Biol Chem; 2005 Sep; 280(36):32026-34. PubMed ID: 16040601
[TBL] [Abstract][Full Text] [Related]
14. Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity.
Todi SV; Laco MN; Winborn BJ; Travis SM; Wen HM; Paulson HL
J Biol Chem; 2007 Oct; 282(40):29348-58. PubMed ID: 17693639
[TBL] [Abstract][Full Text] [Related]
15. Ataxin-3 regulates aggresome formation of copper-zinc superoxide dismutase (SOD1) by editing K63-linked polyubiquitin chains.
Wang H; Ying Z; Wang G
J Biol Chem; 2012 Aug; 287(34):28576-85. PubMed ID: 22761419
[TBL] [Abstract][Full Text] [Related]
16. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein.
Saunders HM; Gilis D; Rooman M; Dehouck Y; Robertson AL; Bottomley SP
Protein Sci; 2011 Oct; 20(10):1675-81. PubMed ID: 21780213
[TBL] [Abstract][Full Text] [Related]
17. Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117.
Todi SV; Scaglione KM; Blount JR; Basrur V; Conlon KP; Pastore A; Elenitoba-Johnson K; Paulson HL
J Biol Chem; 2010 Dec; 285(50):39303-13. PubMed ID: 20943656
[TBL] [Abstract][Full Text] [Related]
18. Ataxin-3 is a multivalent ligand for the parkin Ubl domain.
Bai JJ; Safadi SS; Mercier P; Barber KR; Shaw GS
Biochemistry; 2013 Oct; 52(42):7369-76. PubMed ID: 24063750
[TBL] [Abstract][Full Text] [Related]
19. Functional interactions as a survival strategy against abnormal aggregation.
Masino L; Nicastro G; Calder L; Vendruscolo M; Pastore A
FASEB J; 2011 Jan; 25(1):45-54. PubMed ID: 20810784
[TBL] [Abstract][Full Text] [Related]
20. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
